NO891286L - PROCEDURE FOR THE MANUFACTURE OF NEW ALKANPHENONS. - Google Patents

PROCEDURE FOR THE MANUFACTURE OF NEW ALKANPHENONS.

Info

Publication number
NO891286L
NO891286L NO89891286A NO891286A NO891286L NO 891286 L NO891286 L NO 891286L NO 89891286 A NO89891286 A NO 89891286A NO 891286 A NO891286 A NO 891286A NO 891286 L NO891286 L NO 891286L
Authority
NO
Norway
Prior art keywords
optionally
lower alkyl
salt
denotes
obtainable according
Prior art date
Application number
NO89891286A
Other languages
Norwegian (no)
Other versions
NO891286D0 (en
NO171555B (en
NO171555C (en
Inventor
Andreas Von Sprecher
Andreas Beck
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO891286D0 publication Critical patent/NO891286D0/en
Publication of NO891286L publication Critical patent/NO891286L/en
Publication of NO171555B publication Critical patent/NO171555B/en
Publication of NO171555C publication Critical patent/NO171555C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Substituted alkanophenones of the general formula <IMAGE> in which R1 denotes optionally fluorinated lower alkyl, R2 represents hydrogen, optionally fluorinated lower alkyl or lower alkenyl, X denotes lower alkylene, oxy, thio or a direct bond, alk represents lower alkylene, n stands for 1 or 2, R3 denotes phenyl which is unsubstituted or substituted by optionally fluorinated lower alkyl, etherified or esterified hydroxyl, optionally lower alkylated amino and/or optionally esterified or amidated carboxyl or denotes lower alkyl which is optionally fluorinated or substituted by optionally esterified or amidated carboxyl, R4 represents optionally esterified or amidated carboxyl or 5-tetrazolyl and R5 stands for hydrogen or lower alkyl, have leukotriene-antagonist properties and can be used as antiallergic pharmaceutical active compounds. The process for their preparation is characterised in that an epoxide of the formula <IMAGE> in which R1, R2, X, alk, n and R3 have the above meanings, is reacted with a thiol of the formula <IMAGE> in which R4 and R5 have the above meanings, or a salt thereof and, if desired, a compound obtainable according to the process is converted into another compound of the formula I, a stereoisomer mixture obtainable according to the process is resolved into the components and/or a free compound obtainable according to the process is converted into a salt or a salt obtainable according to the process is converted into the free compound or into another salt.
NO891286A 1988-03-29 1989-03-28 ANALOGY PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTIC-ACTIVE, SUBSTITUTED ALKANPHENONES NO171555C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH118688 1988-03-29
CH385788 1988-10-14

Publications (4)

Publication Number Publication Date
NO891286D0 NO891286D0 (en) 1989-03-28
NO891286L true NO891286L (en) 1989-10-02
NO171555B NO171555B (en) 1992-12-21
NO171555C NO171555C (en) 1993-03-31

Family

ID=25686932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891286A NO171555C (en) 1988-03-29 1989-03-28 ANALOGY PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTIC-ACTIVE, SUBSTITUTED ALKANPHENONES

Country Status (19)

Country Link
EP (1) EP0335315B1 (en)
JP (1) JP2777183B2 (en)
KR (1) KR0125933B1 (en)
AT (1) ATE107639T1 (en)
AU (1) AU623383B2 (en)
CA (1) CA1340463C (en)
CY (1) CY1967A (en)
DE (1) DE58907920D1 (en)
DK (1) DK148989A (en)
ES (1) ES2056137T3 (en)
FI (1) FI94342C (en)
HK (1) HK192696A (en)
HU (2) HU202852B (en)
IE (1) IE66248B1 (en)
IL (1) IL89713A0 (en)
NO (1) NO171555C (en)
NZ (1) NZ228477A (en)
PT (1) PT90125B (en)
YU (1) YU63089A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
US6596260B1 (en) * 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
HUP9800641A3 (en) 1995-04-14 2001-04-28 Glaxo Wellcome Inc Res Triangl Metered dose inhaler for beclomethasone dipropionate
EE03997B1 (en) 1995-04-14 2003-04-15 Glaxo Wellcome Inc. Albuterol metered dose inhaler
JPH11503352A (en) 1995-04-14 1999-03-26 グラクソ、ウェルカム、インコーポレーテッド Metered dose inhaler for fluticasone propionate
ATE297773T1 (en) * 1995-04-14 2005-07-15 Smithkline Beecham Corp DOSAGE INHALER FOR SALMETEROL
IT1320162B1 (en) 2000-02-09 2003-11-18 Rotta Research Lab DERIVATIVES OF THYROSIN WITH ANTI LEUKOTRIENIC ACTIVITY, PROCEDURES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE.
DE60127705T2 (en) 2000-10-23 2007-12-27 Arizona Biomedical Research Commission, Phoenix ANTITUMOR COMPOUNDS BASED ON THE REGULATION OF PROTEIN PRENYLATION
EP2565178A1 (en) 2002-10-03 2013-03-06 Ono Pharmaceutical Co., Ltd. LPA Receptor Antagonists
ATE528276T1 (en) 2003-12-19 2011-10-15 Ono Pharmaceutical Co LYSOPHOSPHATIDYL ACID RECEPTOR ANTAGONIST COMPOUNDS AND THEIR APPLICATIONS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017332B1 (en) * 1979-03-20 1985-07-31 FISONS plc Pharmaceutical heterocyclic compounds, processes for their preparation and compositions containing them
EP0079637B1 (en) * 1981-11-12 1987-01-28 FISONS plc Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
AU548450B2 (en) * 1983-08-08 1985-12-12 G.D. Searle & Co. Substituted dihydrobenzopyrans
EP0147217A3 (en) * 1983-12-27 1986-08-13 Merck Frosst Canada Inc. Leukotriene antagonists
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US4546194A (en) * 1984-05-29 1985-10-08 G. D. Searle & Co. Substituted chromanon-2-yl alkanols and derivatives thereof
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones

Also Published As

Publication number Publication date
DE58907920D1 (en) 1994-07-28
PT90125A (en) 1989-11-10
IE66248B1 (en) 1995-12-27
ATE107639T1 (en) 1994-07-15
KR0125933B1 (en) 1997-12-26
JP2777183B2 (en) 1998-07-16
YU63089A (en) 1990-12-31
CA1340463C (en) 1999-03-23
KR890014511A (en) 1989-10-24
IL89713A0 (en) 1989-09-28
HU202852B (en) 1991-04-29
DK148989D0 (en) 1989-03-28
NO891286D0 (en) 1989-03-28
EP0335315B1 (en) 1994-06-22
IE890935L (en) 1989-09-29
ES2056137T3 (en) 1994-10-01
PT90125B (en) 1994-10-31
AU623383B2 (en) 1992-05-14
NZ228477A (en) 1990-11-27
AU3225289A (en) 1989-10-12
JPH01299283A (en) 1989-12-04
HUT49599A (en) 1989-10-30
NO171555B (en) 1992-12-21
EP0335315A1 (en) 1989-10-04
FI94342B (en) 1995-05-15
FI891362A (en) 1989-09-30
CY1967A (en) 1997-07-04
HU210531A9 (en) 1995-04-28
NO171555C (en) 1993-03-31
FI891362A0 (en) 1989-03-22
FI94342C (en) 1995-08-25
DK148989A (en) 1989-09-30
HK192696A (en) 1996-10-25

Similar Documents

Publication Publication Date Title
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
KR900006318A (en) Piperidinyl Benzimidazole
NO891286D0 (en) PROCEDURE FOR THE MANUFACTURE OF NEW ALKANPHENONS.
KR910020006A (en) Oxazolidinone
EA199801000A1 (en) DERIVATIVES OF ALKYLAMINOBENZOIAZOLE AND -BENZOXOL
SE7906472L (en) NEW 3- (AMINOETHYL) -PHENOL DERIVATIVES AND SALTS THEREOF, SET FOR PREPARATION AND USE OF THEM AS MEDICINAL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
KR890001965A (en) Spurgualine Related Derivatives
KR890001969A (en) Sulfur compounds, their preparations and pharmaceutical compositions containing them
SE8100846L (en) ANTIRINOVIRUSMEDEL
AU1101792A (en) New phenylethanolamino- and phenylethanolaminomethyltetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
JPS5581846A (en) Novel 2*4*66triiodooisophthalamic acid derivative*its manufacture and x ray contrast agent containing it
ES2053868T3 (en) 3-AMINOSIDNONIMINAS SUBSTITUTED, PROCEDURES FOR ITS OBTAINING AND ITS EMPLOYMENT.
ES8500924A1 (en) Phenyl-acetic-acid derivatives, their preparation and pharmaceutical compostions containing them.
IL87796A0 (en) Substituted 3-aminosydnonimines,their preparation and pharmaceutical compositions containing them
GB2111056A (en) Derivatives of 1, 4-thiazane-carboxylic acid preparation and utilization thereof and compositions containing same
FI810255L (en) NYA 17-AMINO-16-HYDROXISTEROIDER UR ANDROSTAN- AND ESTRANSERIER OCH DERAS DERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
KR890009903A (en) New compounds effective as brain failure improving agents

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003